News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Clinical - Post-Approval (World)
Novo Nordisk A/S (NVO) Release: Tresiba Trial Shows That People With Type 2 Diabetes Who Avoid Severe Hypoglycemia Have A Reduced Risk Of Death 9/15/2017
LEO Pharma Announces More Than Half Of Patients On Kyntheum (Brodalumab) Maintain Consistent Levels Of Complete Skin Clearance For More Than Two Years 9/14/2017
Novo Nordisk A/S (NVO) Release: Xultophy Reduces Cardiovascular Risk Factors In People With Type 2 Diabetes 9/13/2017
Genomic Health (GHDX) Release: New Analysis From German Study Group Prospective Trial Shows Minimal Distant Recurrence In Patients With Clinically High-Risk Breast Cancer And Low Oncotype DX Breast Recurrence Score® Results Following Five Years Of Hormone Therapy Alone 9/12/2017
First Patients Enrolled In UK’s Early Access To Medicines Scheme For Santhera (SANN.SW)a’s Raxone In Duchenne Muscular Dystrophy (DMD) 9/12/2017
Boehringer Ingelheim Release: Safety And Efficacy Results From The INJOURNEY Trial Investigating OFEV (Nintedanib) With Add-On Pirfenidone Provide New Data To Support Nintedanib’s Key Role In IPF 9/11/2017
Theraclion Reports Publication Of Promising Clinical Trial Results In A New Thyroid Indication 8/30/2017
Boehringer Ingelheim Release: Pradaxa (Dabigatran Etexilate) Dual Therapy Showed Lower Rates Of Major Bleeding Versus Triple Therapy With Warfarin In Atrial Fibrillation Patients Undergoing Stent Placement 8/28/2017
Johnson & Johnson (JNJ)'s New Xarelto Data Could Bring In $1.5 Billion In The U.S. Alone 8/28/2017
Bristol-Myers Squibb (BMY) And Pfizer (PFE) Present Observational Real-World Data Analysis On The Effectiveness And Safety Of Eliquis (Apixaban) Compared To Warfarin In Select High-Risk Patients With Non-Valvular Atrial Fibrillation 8/28/2017
AstraZeneca PLC (AZN)'s Brilinta Cuts Repeat Heart Attack Risk By Almost A Third 8/24/2017
Mallinckrodt (MNK) Enrolls First Patient In Phase IV Registry Of INOMAX (Nitric Oxide) Gas For Inhalation For Pulmonary Hypertension In Neonates 8/1/2017
Boehringer Ingelheim Starts Clinical Study On Interchangeability Between Its Adalimumab Biosimilar Candidate And HUMIRA 7/27/2017
ViiV Healthcare Announces Superior Efficacy Of Dolutegravir Versus Lopinavir/Ritonavir In Second-Line HIV Treatment In Resource-Limited Settings 7/25/2017
Medtronic (MDT) Release: Five-Year Data Demonstrate Interstim Therapy Offers Sustained Long-Term Efficacy And Quality Of Life Improvements For Overactive Bladder Patients 7/17/2017
Lipogems Release: New Prospective, Randomized Controlled Study Compares The Safety And Performance Of A Next Generation Adipose Tissue Technology (Lipogems) Vs. Platelet Rich Plasma In Patients With Knee Osteoarthritis 7/11/2017
ALK - Five-year GRAZAX Asthma Prevention (GAP) Trial Reveals Benefits Of Early Treatment Intervention In Children 7/7/2017
ALK: Five-year GRAZAX Asthma Prevention (GAP) Trial Reveals Benefits Of Early Treatment Intervention In Children 7/5/2017
PerkinElmer (PKI) Release: Groundbreaking Multi-Center Clinical Trial Confirms Low-Dose Aspirin Therapy Reduces Rate Of Pre-Term Preeclampsia 6/28/2017
Neovii Pharma: Long-Term Outcomes After Standard Graft-Versus-Host Disease (GvHD) Prophylaxis In Hemopoietic Cell Transplantation From Matched Unrelated Donors Strongly Support The Use Of Grafalon (Anti-Human-T-Lymphocyte Immunoglobulin) As Standard Therapy 6/26/2017
Novo Nordisk A/S (NVO) Release: Tresiba Demonstrated No Increased Risk Of Major Cardiovascular Events And Significant Reduction In Rates Of Severe Hypoglycaemia Compared To Insulin Glargine U100 In The DEVOTE Trial 6/13/2017
Mylan (MYL) And BioCon (BIOCON.NS) Present Clinical Data On Insulin Glargine At The American Diabetes Association's 77th Scientific Sessions 6/12/2017
Plandai Biotechnology, Inc. (PLPL.OB) Announces Phytofare To Be Focus Of Human Clinical Trial For Type II Diabetes In Mauritius 5/18/2017
Cinfa Biotech S.L. Announces Positive Top-Line Data From Second Clinical Study With Pegfilgrastim Biosimilar Candidate B12019 5/17/2017
Mithra Pharmaceuticals To Initiate PK Study For Estelle 5/12/2017
Gilead (GILD) Release: Multiple Provinces And Territories Demonstrate Leadership In The Treatment Of HIV/AIDS By Providing Access To GENVOYA 5/8/2017
Teva (TEVA) Announces Publication Of COPAXONE (Glatiramer Acetate Injection) Pregnancy Data In The International Journal Of MS Care 5/5/2017
Britannia Pharmaceuticals Limited: Landmark Apomorphine Study Confirms Its Established Role As A Highly Effective Treatment For Parkinson's Disease Patients Whose Symptoms Cannot Be Controlled On Standard Therapies 4/26/2017
Bioness Receives CE Mark Certification For The L300 Go System 4/25/2017
Novartis AG (NVS) Real-World Data At Aan Confirms Benefit Of Gilenya On Four Key Measures Of Disease Activity In Relapsing MS 4/24/2017
eClinicalHealth Celebrates 5 Years In Business Supporting Direct-to-Patient Research Models For Clinical Trials 3/27/2017
Horizon Pharma (HZNP) To Present Data On RAVICTI (Glycerol Phenylbutyrate) Oral Liquid For Urea Cycle Disorder Patients Aged Two Months To Two Years 3/22/2017
Oncolytics Biotech Inc. (ONC.TO) Enters Into First-In-Class Collaboration With Myeloma UK And Celgene (CELG) Using REOLYSIN In Combination With Imnovid Or Revlimid In Patients With Myeloma 3/16/2017
GlaxoSmithKline (GSK) Release: Positive Results For Relvar Ellipta Lung Function Study In Patients With Well-Controlled Asthma 2/23/2017
First Patient Enrolled In Mallinckrodt (MNK) Phase 4 Trial Of H.P. Acthar Gel For Lupus 11/15/2016
UCB, Inc. (UCBJF.PK) Release: The Lancet Publishes First Head-To-Head Study Of CIMZIA (Certolizumab Pegol) And Humira (Adalimumab) In Bio-Naïve Rheumatoid Arthritis Patients 11/15/2016
First Patient Enrolled In Mallinckrodt (MNK) Phase 4 Trial Of H.P. Acthar Gel For Rheumatoid Arthritis 11/14/2016
Horizon Pharma (HZNP) Presents Data On KRYSTEXXA (Pegloticase) For The Management Of Refractory Chronic Gout At The 2016 ACR/ARHP Annual Meeting 11/14/2016
Bayer (BAY) Release: 20+ Years Of Safety Data, Clinical Trials & Real-World Use Confirm Positive Benefit/Risk Profile Of ALEVE 11/14/2016
AstraZeneca PLC (AZN) Suffers Another Blow After Blood-Thinning Drug Flunks Trial 10/4/2016
Novartis AG (NVS) Data Finds Relapsing MS Patients On Gilenya Had Greater Treatment Retention And Satisfaction Rates Vs. Injectable DMTs 9/16/2016
Boehringer Ingelheim Release: New Long-Term Data Demonstrates Continued Safety And Beneficial Effect Of OFEV (Nintedanib) For Patients With IPF 9/7/2016
Vectura (VEC.L) Release: New Findings Confirm Ultibro Breezhaler Consistently More Effective Than Seretide In Reducing COPD Flare-Ups Across Different Patient Groups 9/6/2016
AstraZeneca PLC (AZN)'s Long-Acting Asthma Drug Symbicort Safe in Two Trials 9/1/2016
Seqirus Presents Analysis Reinforcing The Safety And Immunogenicity Profiles Of Its MF59-Adjuvanted Seasonal Trivalent Influenza Vaccine In Adults 65 Years And Older 8/29/2016
Novo Nordisk A/S (NVO)'s Blockbuster Diabetes Med Victoza Does Not Help Severe Heart Failure 8/4/2016
Roche (RHHBY) CEO 'Sleeping Much Better' Following Positive News About Three New Drugs 6/23/2016
Boehringer Ingelheim And Eli Lilly (LLY) Release: Jardiance (Empagliflozin) Significantly Reduced The Risk Of Progressive Kidney Disease In Adults With Type 2 Diabetes With Established Cardiovascular Disease 6/14/2016
Boehringer Ingelheim And Eli Lilly (LLY) Release: New Study Results Show Trajenta (Linagliptin) Reduces Blood Sugar In Adults With Type 2 Diabetes At Risk For Kidney Impairment 6/13/2016
After Initial Miss, GlaxoSmithKline (GSK)'s Pioneering Lung Study Shows Positive Results 5/24/2016
No Suicide Risk Linked to Pfizer (PFE)'s Chantix 4/25/2016
Health Canada Approves BioPharmX Study Of Violet Iodine 4/4/2016
Specialised Therapeutics Asia Release: Novel Multiple Myeloma Drug Aplidin Shows Positive Results In Pivotal Phase 3 Study 3/31/2016
AstraZeneca PLC (AZN) Release: BRILINTA Preferred Over Clopidogrel In Updated American College of Cardiology And AHA Guideline In Acute Coronary Syndrome 3/31/2016
Boehringer Ingelheim Launches RE-COVERY DVT/PE: Global Observational Study On Management Of Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) With Pradaxa (Dabigatran Etexilate) 3/23/2016
AstraZeneca PLC (AZN)'s Brilinta Fails to Hit Main Goal of Stroke Study 3/23/2016
Viralytics Ltd (VLA.AX) Release: Positive CAVATAK Clinical Data Presented At 2016 European Association Of Urology Congress 3/15/2016
AstraZeneca PLC (AZN), Novo Nordisk A/S (NVO) Investors Pin Hopes on Data from Two Closely-Watched Trials 3/2/2016
Boehringer Ingelheim Release: New Analysis Confirms OFEV® (Nintedanib) Slows Disease Progression In IPF And Reduces Risk Of Acute Exacerbations 2/25/2016
Teva (TEVA), Active Biotech (BTPC) Stop Higher Doses of Laquinimod in Two Multiple Sclerosis Trials 1/4/2016
Researchers Find Additional Benefits of Novartis AG (NVS)'s Heart Failure Drug Entresto 12/3/2015
VBL Therapeutics (VBLX) Announces Significant Improvement Of 12 Month Overall Survival With VB-111 Compared To Pooled Data From Four Avastin Studies At The Annual Meeting Of The Society For Neuro-Oncology 11/19/2015
Boehringer Ingelheim Release: New Jardiance (Empagliflozin) Data Show Improved CV Outcomes Regardless Of Heart Failure Status At Baseline 11/9/2015
Boehringer Ingelheim Release" CHEST: New Sub-Analyses Show Improvement In COPD Patient Outcomes With Spiolto Respimat 10/28/2015
Mundipharma AG: New Study Provides Insights Into Potential Treatment Of Severe Pain In Parkinson’s Disease With Prolonged-Release Oxycodone/Naloxone 10/20/2015
Novartis AG (NVS) Cancer Drug May Help Parkinson's Patients 10/19/2015
Indian Drugmakers Like Cipla (CIPLA) and BDR Pharma Work on Hepatitis C Cocktails Impossible in the U.S. 10/12/2015
Gedeon Richter (RIG2.F) Release: Full Results Of PEARL IV Study Presented At The European Society Of Gynaecological Endoscopy (ESGE) Congress Confirms The Efficacy Of Ulipristal Acetate 5 Mg For The Long Term Management Of Uterine Fibroids 10/9/2015
Boehringer Ingelheim Release: New Data Demonstrate Sustained Long-Term Efficacy Of OFEV* On Slowing Disease Progression And Safety In Patients With IPF 9/29/2015
MerLion Pharmaceuticals GmbH’s Finafloxacin Shown To Be More Efficacious Than Ciprofloxacin In The Treatment Of Complicated Urinary Tract Infections 9/21/2015
ERS 2015: Landmark Year For Boehringer Ingelheim’s Respiratory Portfolio - New Data For COPD, IPF And Asthma Treatments 9/21/2015
AmpliPhi Biosciences Corporation (APHB) Announces Data Demonstrating Efficacy Of A Novel Bacteriophage Cocktail Is Comparable To Vancomycin In S. Aureus Lung Infection Model 9/21/2015
PharmaMar Showcases New Data For YONDELIS And PM1183 In Soft Tissue Sarcoma And Solid Tumors At ECCO 2015 9/14/2015
GlaxoSmithKline (GSK), Theravance (THRX)'s Breo Fails to Extend Lives in Ambitious Study 9/10/2015
GlaxoSmithKline (GSK) And Theravance (THRX) Announce Results From The SUMMIT COPD CV Survival Study 9/9/2015
Regeneron (REGN) And Sanofi (SNY) Announce New Positive Praluent (alirocumab) Phase 3 Data Presented At ESC Congress 2015 9/1/2015
Novartis AG (NVS) Reports Third Case of PML in Relapsing MS Patient Treated with Gilenya 8/19/2015
Veloxis Pharmaceuticals A/S (VELO) Envarsus XR Granted Orphan Drug Status By FDA For Kidney Transplant Rejection Prophylaxis 8/17/2015
GlaxoSmithKline (GSK) Hopes Huge Trial Will Revive Flagging Lung Drug Biz 8/14/2015
Roche (RHHBY)'s Avastin Not Linked to Higher Risk of Blindness 8/14/2015
Zealand Pharma  (ZEAL.CO) Informs That Data Presented From The ELIXA Study Establish Lyxumia As The First GLP-1 Receptor Agonist With Cardiovascular Safety Proven In A Long-Term Outcome Trial 6/9/2015
Zealand Pharma  (ZEAL.CO) Informs Of Updates Given By Sanofi (SAN.PA) On Lyxumia And Lixilan On An IR Thematic Conference Call On Diabetes 6/9/2015
Zealand Pharma  (ZEAL.CO) Announces That Sanofi (SAN.PA) Has Informed Of Results From Getgoal Duo-2, Showing Advantages Of Lyxumia Versus Rapid-Acting Insulin As Add-On To Lantus For The Treatment Of Type 2 Diabete 6/8/2015
Boehringer Ingelheim Release: First Patient Enrolled In Dabigatran Study Comparing Anticoagulation Strategies During AF Ablation 5/13/2015
Teva (TEVA) Presents Data Comparing Early Treatment With COPAXONE 40 Mg/Ml To Delayed Start Treatment At 67th American Academy of Neurology Annual Meeting In Washington, D.C. 4/23/2015
AstraZeneca PLC (AZN)'s Diabetes Drug Onglyza May Increase Risk of Heart Failure, FDA Panel Reports 4/13/2015
Roche (RHHBY) Scientists Testing to See if Arthritis Blockbuster Will Work for Diabetes 4/10/2015
Hemispherx Biopharma Europe N.V./S.A. Receives Positive Opinion On Application For Orphan Designation By The European Medicines Agency Agency For Ampligen To Treat Patients With Ebola Virus Disease (EVD) 3/24/2015
Boehringer Ingelheim Release: Many Atrial Fibrillation Patients At High Risk Of Stroke Fail To Receive Guideline-Recommended Oral Anticoagulant Treatment 3/16/2015
AstraZeneca PLC (AZN)'s Brilinta Proves Worthy Despite Higher Bleeding Risk 3/16/2015
Celltrion Healthcare: Data Show The World’s First European Medicines Agency-Approved Biosimilar Monoclonal Antibody Remsima Could Reduce Cost Of Treating Crohn’s Disease By Up To €336 Million Over Five Years 2/20/2015
Novartis AG (NVS) May Already Have First True Anti-Aging Drug in Its Pipeline 2/19/2015
New Study Vindicates Efficacy of Roche (RHHBY)'s Blockbuster Drug Tamiflu 2/2/2015
DBV Technologies Announces Publication In The Journal Of Allergy And Clinical Immunology Of Data Demonstrating That Epicutaneous Immunotherapy May Influence The Natural History Of Allergy 1/12/2015
Roche (RHHBY) Suffers A Double Blow As Breast Cancer, Alzheimer’s Drug Studies Fail; Pulls Plug On ALZ's Drug Development 12/23/2014
Genentech (RHHBY) Provides Update On Phase 3 MARIANNE Study In People With Previously Untreated Advanced HER2-Positive Breast Cancer 12/19/2014
EXCLUSIVE: NHS Uses Ineffective IPF Therapy 12/5/2014
National Institute for Clinical Excellence (NICE) Requests More Info On Novartis AG (NVS)'s Xolair To Treat Chronic Hives 11/20/2014
Teva Pharmaceutical Industries Limited (TEVA) Presents Positive Safety And Efficacy Data For QNASL® (Beclomethasone Dipropionate) Nasal Aerosol In Treating Children With Perennial Allergic Rhinitis 11/7/2014
Changing The Way We Combat Bacterial Infections: Dutch Biotech Micreos Launches First Bacteria-Killing Enzyme For Human Use Against MRSA 11/5/2014
AstraZeneca PLC (AZN)'s New Drug Olaparib May Also Work In Prostate Cancer 11/5/2014
Teva Pharmaceutical Industries Limited (TEVA) And Active Biotech AB (BTPC) Announce Expansion Of Laquinimod Clinical Development Program With New Trial In Primary Progressive Multiple Sclerosis And First Patient Screened In Huntington’s Disease Trial 11/4/2014
Otsuka America Pharmaceutical, Inc. And H. Lundbeck A/S (LUN.CO) Release: Aripiprazole Once-Monthly Injectable Shows Superior Effectiveness To Paliperidone Palmitate Once-Monthly Injectable On Quality Of Life Scale In Patients With Schizophrenia 11/3/2014
Boehringer Ingelheim GmbH Release: FDA Medicare Study In 134,000 Atrial Fibrillation Patients Confirms Positive Safety Profile And Effectiveness Of Pradaxa® In General Practice 11/3/2014
Roche (RHHBY), Merck & Co. (MRK) Extend Immunotherapy Battle To Breast Cancer 10/17/2014
Celgene International Sárl (CELG) Release: New Analyses Of Oral OTEZLA® (Apremilast) Presented At EADV Show Efficacy In Difficult-To-Treat Areas Of Moderate To Severe Plaque Psoriasis 10/10/2014
Celgene International Sárl (CELG) Release: Oral OTEZLA® (Apremilast) Data Presented At EADV Show Improved Measures Of Health-Related Quality Of Life And Work Productivity In Patients With Moderate To Severe Plaque Psoriasis 10/10/2014
Celgene International Sárl (CELG) To Present Long-Term Efficacy And Safety Data On Oral OTEZLA® (Apremilast) In Plaque Psoriasis And Psoriatic Arthritis At European Academy Of Dermatology And Venereology Congress 10/7/2014
Daiichi Sankyo, Inc. (4568.t) Receives Approval For Additional Indications Of LIXIANA® (Edoxaban) In Japan 9/26/2014
Regeneron Pharmaceuticals, Inc. (REGN) Announces EYLEA® (aflibercept) Injection Approved For The Treatment Of Patients With Myopic Choroidal Neovascularization (CNV) In Japan 9/22/2014
Janssen-Cilag International NV (JNJ) Release: Results From Head-To-Head Studies Of INVOKANA® (Canagliflozin) Versus JANUVIA (Sitagliptin) Highlight The Importance Of Weight-Change On Quality Of Life And Cost Effectiveness Of Canagliflozin Among People With Type 2 Diabetes 9/17/2014
Study Shows Novo Nordisk A/S (NVO)'s New Diabetes Drug Tresiba Effective And Safe For Children 9/16/2014
Teva Pharmaceutical Industries Limited (TEVA) Presents New Data Which Demonstrate Reduction Of Injection-Related Adverse Events With The Less Frequent Dosing Of Three-Times-A-Week COPAXONE® (Glatiramer Acetate Injection) 40 Mg Compared To Daily COPAXONE® 20 Mg 9/11/2014
Novartis AG (NVS): Rate Of Brain Shrinkage Faster In Multiple Schlerosis Patients 9/10/2014
Novaliq GmbH Announces Positive Results From Novatears® Observational Study In Mild To Moderate Evaporative Dry Eye Disease 9/10/2014
Amgen (AMGN), Servier Heart Drug Runs Into Safety Concerns In Major Clinical Study 9/4/2014
Vifor Pharma Release: CONFIRM-HF Study Demonstrates That Injectafer® (Ferinject®) Improves Exercise Capacity In Patients With Chronic Heart Failure 9/2/2014
Boehringer Ingelheim Corporation Release: European Society of Cardiology Congress 2014 Hot Line Session: Favourable Effect Of Pradaxa® On Kidney Function Over Time Compared To Warfarin 9/2/2014
Sanofi Pasteur (SASY.PA) Touts Positive Trial Data For Fluzone High-Dose Vaccine 8/14/2014
Scientists Retract Narcolepsy Study Linked To GlaxoSmithKline (GSK) Flu Vaccine 8/11/2014
Study Claims Celgene (CELG) Drug Can Drive HIV Out Of Hiding 7/25/2014
CTI BioPharma Expands Access To PIXUVRI® With Approval In Israel And Add-on Reimbursement Status In The Netherlands 7/21/2014
Shire Reports Results From Two Head-To-Head Studies Comparing Vyvanse® With Concerta® In ADHD Study 7/18/2014
Merck & Co., Inc. (MRK)'s Gardasil HPV Vaccine Doesn't Increase Blood Clot Risk 7/9/2014
Roche (RHHBY) Finds "Serious Flaws" In Recent Study Doubting Tamiflu's Effectiveness 7/1/2014
Veloxis Pharmaceuticals A/S (VELO) Release: Envarsus® XR Demonstrates Lower Treatment Failure Rate In African-Americans Compared To Twice-Daily Tacrolimus (Prograf®) 6/30/2014
H. Lundbeck A/S (LUN.CO) Release: New Study Results Demonstrate Brintellix® (Vortioxetine) Is Efficacious In Asian Patients Suffering From Depression 6/26/2014
A 4-Week Hepatitis C Cure? Bristol-Myers Squibb Company (BMY) To Test Drugs With Gilead Sciences, Inc. (GILD)'s Sovaldi 6/23/2014
H. Lundbeck A/S (LUN.CO) Release: Brintellix® Demonstrated A Statistically Significantly Superior Improvement Compared To Escitalopram In Improving Sexual Functioning In Well Treated Patients Suffering From Depression And Experiencing Treatment-Emergent Sexual Dysfunction 6/17/2014
Zealand Pharma  (ZEAL.CO) Provides Summary Of New Clinical Data And Information On Lyxumia® (Lixisenatide) And Lixilan Presented At The American Diabetes Association’s 74th Scientific Sessions 6/17/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) Release: Results Of A New Study Of Brintellix® (vortioxetine) vs. Escitalopram On Sexual Functioning In Well Treated MDD Patients Experiencing Treatment-Emergent Sexual Dysfunction 6/17/2014
H. Lundbeck A/S (LUN.CO) Release: New Study Shows That Brintellix® (Vortioxetine) Improves Cognitive Performance And Function In Adult Patients With Major Depression 6/16/2014
Hemispherx Biopharma (HEB) Announces New Publication With Potential Insight Into High Mortality Rate In Middle Eastern Respiratory Syndrome (MERS) 6/16/2014
Pfizer Inc. (PFE) To Showcase Over 10 Abstracts For XELJANZ® At Major Conference 6/11/2014
Boehringer Ingelheim Corporation Release: Antidote For Rapid Reversal Of Pradaxa® (Dabigatran Etexilate) Progresses Into Next Stage Of Clinical Investigation With Study In Patients 5/22/2014
GlaxoSmithKline (GSK) Touts Positive Incruse™-Ellipta®-Advair®-Diskus® Combo Data 5/20/2014
Biohit Release: Enrollment To Clinical Trials For Prevention Of Migraine-Type Headache 5/19/2014
Biohit Starts Two Clinical Trials With Acetium® Capsule For Prevention Of Migraine-Type Headache 4/29/2014
Head-To-Head Study Reveals Novartis AG (NVS) Lung Drug Not Inferior To GlaxoSmithKline (GSK)'s Seretide 4/28/2014
Saga Continues: Roche (RHHBY)'s Tamiflu No Better Than Tylenol At "Fighting Flu" 4/14/2014
FDA Grants Breakthrough Status Designation To Novartis AG (NVS)' Meningitis B Vaccine 4/8/2014
H. Lundbeck A/S (LUN.CO) Release: Treatment With Once-Monthly Abilify Maintena® (Aripiprazole) Significantly Reduces Hospitalisation Rates For Patients With Schizophrenia Compared With Daily Oral Antipsychotics 4/7/2014
Roche (RHHBY)-Backed Study Finds Tamiflu Saved Lives In Flu Pandemic 3/19/2014
uniQure And Chiesi Farmaceutici SpA Announce Six Year Follow-up Data from Glybera® Treated Patients 3/17/2014
Janssen Pharmaceutica N.V. Release: New Data Show XEPLION® Significantly Delays Time To Relapse Compared To Treatment As Usual With Oral Antipsychotic Monotherapy 3/4/2014
Baxter International, Inc. (BAX) Presents Data At EAHAD From Long-Term Outcomes Registry Reinforcing Prophylaxis Treatment Experience With ADVATE 2/27/2014
Roche (RHHBY) May Share Avastin Brain Cancer Data Amid Conflicting Results 2/21/2014
Ranbaxy Laboratories (RANBAXY.BO) Workers Fudged Test Results: FDA 1/28/2014
Teva Pharmaceutical Industries Limited (TEVA) Release: Data Demonstrates Key Genes Respond Differently To COPAXONE® (glatiramer acetate injection) Versus A Purported Generic Glatiramer Acetate 1/13/2014
German Watchdog Deals Setback To Bayer AG (BAYN.DE) Eye Drug Eylea 1/6/2014
AstraZeneca PLC (AZN)'s Arimidex Halves Breast Cancer Risk, Study Finds 12/12/2013
Lundbeck Inc. (LUN.CO) Release: New Study Showed Improvement In Cognitive Performance In Adult Patients Treated With Brintellix® (Vortioxetine) For Acute Episodes Of Major Depression 12/11/2013
Zealand Pharma  (ZEAL.CO) Informs That New Data Presented At The World Diabetes Congress Support Flexibility In Timing Of Administration For Lyxumia® 12/5/2013
Janssen Pharmaceutica N.V. Unveils New Data On Xeplion® In Various Stages Of Schizophrenia 12/2/2013
Boehringer Ingelheim Corporation Release: Pradaxa® (Dabigatran Etexilate) 150mg Bid Continues To Be The Only Oral Anticoagulant Which Showed Superior Ischaemic Stroke Reduction Vs. Warfarin In Its Pivotal Study RE-LY® 11/25/2013
Boehringer Ingelheim Corporation Planning Two New Global Clinical Trials For Pradaxa® (Dabigatran Etexilate) In Expanded Patient Populations 11/19/2013
First Human Data Show Promise Of Boehringer Ingelheim Corporation’s Specific Antidote For Immediate, Complete And Sustained Reversal Of Pradaxa®-Induced Anticoagulation 11/18/2013
EU Agency Questions AstraZeneca PLC (AZN) Over Heart Drug Trial 11/8/2013
Ibuprofen No Good in Treating Colds or Sore Throats, University of Southampton Study 11/5/2013
Roche (RHHBY)'s Avastin Boosts Survival in Advanced Ovarian Cancer 10/23/2013
Novo Nordisk A/S (NVO) Study Shows Tresiba Efficacy for Diabetes 9/26/2013
Data Show Sanofi (France) (SAN.PA)'s Lyxumia® Added to Basal Insulin Lowered Blood Sugar Especially When Fasting Plasma Glucose Was Controlled 9/24/2013
Roche (RHHBY)'s Perjeta Works in Early-Stage Breast Cancer 9/11/2013
Boehringer Ingelheim GmbH's Respimat Inhaler Meets Safety Goal in Study 9/3/2013
FDA Probes Brain Infection in Patient on Novartis AG (NVS)'s MS Drug 9/3/2013
Novartis AG (NVS)'s Afinitor® Fails Phase 3 Liver Cancer Trial 8/8/2013
Orexo AB: First Patient Dosed in New Study on Long-Term Adherence to Treatment of Opioid Dependence With Zubsolv® 8/7/2013
Deja Vu: Second Probe Finds Manipulated Trial Data for Novartis AG (NVS) Drug 8/5/2013
Celgene International Sárl (CELG) Release: Study of REVLIMID® (lenalidomide) in Patients with High-Risk Asymptomatic Smoldering Multiple Myeloma Published in The New England Journal of Medicine 8/1/2013
European Medicines Agency Approves SmPC Change to Baxter International, Inc. (BAX)’s ADVATE to Include Information on PK-Guided Dosing Study 7/22/2013
Roche (RHHBY)'s Avastin as Good as Novartis AG (NVS)'s Lucentis for AMD 7/19/2013
Boehringer Ingelheim Corporation Release: Benefits of Pradaxa® Maintained in Difficult to Treat Patients With Atrial Fibrillation and Symptomatic Heart Failure 7/16/2013
Novartis AG (NVS) Drug Study Data Manipulated: Kyoto Prefectrual University of Medicine 7/16/2013
Baxter International, Inc. (BAX) Presents ADVATE Data on Prophylaxis Management and Efficacy for Hemophilia A Patients 7/8/2013
Boehringer Ingelheim Corporation Release: New Long-Term Data Reinforce Safety Profile of Pradaxa® for Stroke Prevention in AF 6/17/2013
Celgene International Sárl (CELG) Oral Anti-Cancer Therapy REVLIMID® (lenalidomide) Now Indicated as a Treatment for Patients With Rare Form of Blood Disease 6/17/2013
Novo Nordisk A/S (NVO) Release: Victoza® (Liraglutide [rDNA Origin] Injection) Safety Profile Further Supported at Scientific Workshop on Pancreatitis, Diabetes and Pancreatic Cancer 6/14/2013
AbbVie (ABBV) Presents First Study Assessing the Role of Predefined Doses of Methotrexate When Used in Combination With HUMIRA™ (adalimumab) for Rheumatoid Arthritis 6/13/2013
Bristol-Myers Squibb Company (BMY)'s Orencia Matches Abbott Laboratories (ABT)' Humira in Arthritis Study 6/12/2013
Merck & Co., Inc. (MRK) Joins Novo Nordisk A/S (NVO) to Reassure Safety of Diabetes Drugs 6/12/2013
Sanofi (France) (SAN.PA) Steps Up Diabetes Drive as Rivals Raise the Stakes 6/10/2013
Eisai Company, Ltd. (ESALY.PK) Confirms Therapeutic Effects of Lenvatinib in Patients With Melanoma in Strategic Collaboration With Quintiles, Inc. (Q) to Develop Eisai Anticancer Compounds 6/10/2013
New Bird Flu Found to be Resistant to Roche (RHHBY)'s Tamiflu 5/30/2013
Boehringer Ingelheim Corporation Release: New European Survey Highlights Ischaemic Stroke Protection as Treatment Priority for Patients With Atrial Fibrillation 5/28/2013
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S (LUN.CO): Study Shows Effects of Treatment With ABILIFY MAINTENA#0153; (Aripiprazole) on Psychiatric Hospitalization Rates for Patients With Schizophrenia1 5/21/2013
"Love Hormone" Promises Safer Births After Pfizer Inc. (PFE) Flop 5/21/2013
Teva Pharmaceutical Industries Limited (TEVA) Parkinson's Treatment Meets Study Goals 3/20/2013
German Cost Regulator Rejects Bayer AG (BAY.F) and Regeneron Pharmaceuticals, Inc. (REGN) Eye Drug 3/20/2013
EU Expands Use of Roche (RHHBY)'s Pegasys in Chronic Hepatitis C 3/18/2013
Ferring Pharmaceuticals Data Suggest Lower Risk of Cardiovascular Events or Deaths in Prostate Cancer Patients Treated With Degarelix Compared to LHRH Agonists 3/18/2013
AbbVie (ABBV) Seeks to Block Release of Clinical Trial Data 3/11/2013
Serious Side Effects Seen With Failed Merck & Co., Inc. (MRK) Niacin Drug 3/11/2013
Roche (RHHBY)'s Rituxan Cures Rare Skin-Blistering Disease in Study 3/8/2013
National Institute for Clinical Excellence (NICE) U-Turn on Novartis AG (NVS)'s Xolair for Asthma 3/7/2013
Boehringer Ingelheim Corporation Release: New Findings From Two Studies Support Substantial Benefit of Pradaxa® for Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism 2/21/2013
Pfizer Inc. (PFE) Reports Positive Results in Studies of Toviaz, Pristiq, Chantix 1/24/2013
Novartis AG (NVS) Says Afinitor Reduces Tumors in Rare Genetic Disease 1/11/2013
Merck & Co., Inc. (MRK)'s Tredaptive is Under Review by European Medicines Agency After Failed Trial 12/26/2012
Immune Response BioPharma Files for Orphan Designation of REMUNE for Pediatric HIV/AIDS 12/13/2012
Novo Nordisk A/S (NVO) Bets on Turning Victoza Into Obesity Blockbuster 12/12/2012